膀胱内庆大霉素治疗多重耐药菌所致复发性尿路感染
这项前瞻性试验纳入63例多重耐药病原体所致复发性尿路感染成人,给予夜间膀胱内灌注庆大霉素6个月;平均尿路感染次数从4.8次降至1.0次,病原体耐药率从78%降至23%,未观察到全身吸收或临床相关副作用。
要点
- 膀胱内庆大霉素灌注可减少多重耐药菌所致复发性尿路感染发作次数。
- 治疗期间病原体耐药率由78%降至23%,未见全身吸收或临床相关副作用。
- 该方案为治疗选择有限的患者提供了一种避免静脉使用储备抗生素的可行途径。
核心结论
- 膀胱内灌注庆大霉素可减少尿路感染发作次数并降低病原体耐药程度。
研究设计与样本
- 前瞻性试验,纳入荷兰1家学术医院和1家综合医院2014至2017年间63例多重耐药病原体所致复发性尿路感染成人。
- 干预为夜间膀胱内灌注庆大霉素,持续6个月。
- 主要结局为与之前6个月相比的尿路感染复发率。
主要发现
- 治疗期间平均尿路感染次数从4.8次降至1.0次。
- 病原体耐药率从78%降至23%。
- 未观察到全身吸收或临床相关副作用。
临床怎么用
- 对于多重耐药菌所致复发性尿路感染且治疗选择有限的患者,可考虑膀胱内庆大霉素灌注作为预防性治疗。
- 治疗期间需关注尿路病原体耐药性的变化。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Antimicrobial resistance leads to complications in the management of recurrent urinary tract infections. In some patients with recurrent urinary tract infections who have limited treatment options intravenous therapy with reserve antibiotics is often required. In this study we assessed the effectiveness, safety and feasibility of prophylactic treatment with intravesical gentamicin in patients with refractory recurrent urinary tract infections caused by multidrug resistant microorganisms. MATERIALS AND METHODS: This was a prospective trial of 63 adults with recurrent urinary tract infections caused by multidrug resistant pathogens who were enrolled at 1 academic and 1 general hospital in The Netherlands between 2014 and 2017. The intervention was overnight intravesical instillations of gentamicin for 6 months. The primary outcome was the recurrence rate of urinary tract infections compared to that in the preceding 6 months. Secondary objectives included assessment of the safety of intravesical gentamicin instillation and its influence on the development of antibiotic resistance in uropathogens. RESULTS: The mean number of urinary tract infections was reduced from 4.8 to 1.0 during intravesical treatment. The resistance rate of the uropathogens decreased from 78% to 23%. No systemic absorption or clinically relevant side effects were observed. CONCLUSIONS: Intravesical gentamicin instillation reduced the number of urinary tract infection episodes and the degree of antimicrobial resistance.
引用
- Stalenhoef JE, van Nieuwkoop C, Menken PH, et al. Intravesical Gentamicin Treatment for Recurrent Urinary Tract Infections Caused by Multidrug Resistant Bacteria. J Urol. 2019. PMID: 30316898. doi:10.1016/j.juro.2018.10.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。